MS Treatments Don’t Raise Miscarriage, Birth Defect Risk: Study

Most treatments for multiple sclerosis (MS) don’t increase the risk of major problems when used during pregnancy, an analysis showed. “We found that most therapies were not associated with an increased risk of miscarriage, premature birth or major birth defects,”...

Changing Neurologists Yet Again to Treat My MS

I was diagnosed with multiple sclerosis (MS) in 2014. Over the past 10 years, my MS has been managed by five healthcare providers. That’s not how I envisioned my MS care. I’ve had the same primary care provider for almost 20 years, and I naively thought I’d be able to...

If I Knew Then What I Know Now – Neurologist Visit Considerations

It’s true and I know a good majority of you have thought the same thing. If we only knew then, what we know now, we would have acted sooner rather than later. My journey began sometime around 1985. I assumed my physical changes were due to getting older and I adjusted...

Phase 2 Trial Testing Foralumab in Nonactive SPMS Adds 6 US Sites

Tiziana Life Sciences is expanding its Phase 2 clinical trial testing foralumab nasal spray for the treatment of nonactive secondary progressive multiple sclerosis (SPMS), with six additional clinical sites across the northeastern region of the U.S. The new sites, all...

Finding a Way to Treat the Irritability That Can Come With MS

Too often, I’d find myself amid joyful moments with loved ones, struggling to keep irritability at bay. At those times, my mind would stagger between living in the happiness of the moment or an overwhelming sense of overstimulation, annoyance, and frustration. Most of...

Study IDs 2 Enzymes That Mediate Toxic Effects of Saturated Fats in MS

Two enzymes in brain cells are responsible for mediating the toxic effects of certain fat molecules in multiple sclerosis (MS), a new study in a mouse model of the disease suggests. According to the researchers, these enzymes may serve as potential targets for easing...